On January 23, 2023, DarioHealth Corp. (the “Company”), through its wholly owned subsidiary Labstyle Innovation Ltd., executed a Termination of Employment and Separation Agreement (the “Agreement”) with Dror Bacher, the Company's Chief Operating Officer, pursuant to which Mr. Bacher's position as Chief Operating Officer was terminated with immediate effect. Pursuant to the terms of the Agreement, the Company agreed to retain Mr. Bacher as a member of its advisory board.